| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8260860 | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2013 | 9 Pages |
Abstract
⺠BNP and NT-proBNP are gold standard HF biomarkers in diagnosis and prognosis of HF. ⺠BNP and NT-proBNP-guided HF management look promising. ⺠Novel biomarkers include MR-proANP, MR-proADM, troponins, sST2, GDF-15, galectin-3. ⺠Novel biomarkers show promise in HF prognosis beyond BNP and NT-proBNP. ⺠The role of novel biomarkers in clinical care is still only partially defined.
Keywords
GISSI-HFLVSDNYHANT-proBNPhsTnTADMMR-proANPBNPNHANESHFpEFANPGDF-15N-terminal pro b-type natriuretic peptideMR-proADMST2LADHEREVal-HeFTAUCsST2adrenomedullinMyocardial infarctionICONLeft ventricular systolic dysfunctionNew York Heart AssociationNational Health and Nutrition Examination SurveyBACHBiomarkerDiagnosisgrowth differentiation factor-15Prideconfidence intervalsoluble ST2Managementarea under the curveheart failurehazard ratioatrial natriuretic peptideB-type natriuretic peptideprognosisCorona
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Hanna K. Gaggin, James L. Jr.,